Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Extracorporeal or ex vivo removal of antibodies or immune...
Reexamination Certificate
2005-03-15
2005-03-15
Saunders, David (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Extracorporeal or ex vivo removal of antibodies or immune...
C436S507000, C436S824000, C530S412000, C530S413000, C530S415000, C530S416000, C530S868000, C604S005010, C604S005020
Reexamination Certificate
active
06866846
ABSTRACT:
A process for preparing a patient-specific immunoadsorber, which comprises (i) extracting a body fluid from a patient having an immunopathological condition, the fluid containing immune complexes that are relevant to that immunopathological condition, (ii) contacting the extracted fluid with an adsorbent for the immune complexes to form adsorbed immune complexes, (iii) eluting the adsorbed complexes to form an eluate, (iv) fractionating the eluate into a plurality of immune complex component fractions, and (v) immobilizing the immune complex components on one or more biologically compatible carriers activated to bond to its surface one or more desired immune complex components.
REFERENCES:
patent: 3964467 (1976-06-01), Rose
patent: 4551435 (1985-11-01), Liberti et al.
patent: WO 8607152 (1986-12-01), None
Sueoka, “Present Status of Apheresis Technologies, Part 3: Adsorbent”, Therapeutic Apheresis, 1, 271-283, 1997.*
C. Bruneau et al.: Evidence for a Disease Specific Antigen, etc., Clin. Exp. Immun., 53 (1983), pp. 529-535.
P. C. Dau: Plasmapheresis in Acute Multiple Sclerosis, J. Clin. Apheresis, 6, 1991, pp 200-204.
H. H. Euler et al.: A Randomized Trial of Plasmapheresis, etc., Int. J. Artif. Organs, 14, 1991, pp. 639-646.
D. C. Hess et al.: Thrombotic Thrombocytopenic Purpura in Systemic Lupus Erythematosus. etc., J. Rheumat. 19, 1992, pp. 1474-1478.
R. T. Baldwin et al.: Guillain-Barré Syndrome After Heart Transplantation; J. Heart & Lung Trnsplt., 11, 1992, pp. 817-819.
J. Sany: Early Approaches to Immunotherapy of Rheumatoid Arthritis, Eur.J. Rheumatol. Inflam., 11 (1991) pp. 139-147.
K. Korinthenberg et al.: Verlaufscharacteristik und Therapeutische Mõglichkeiten, Monatschr. Kinderheilk., 140, 1992, pp. 792-798.
T. Pullar: Combination Therapy in Rheumatoid Arthritis, and J. Braun et al.: Severe Lupus Crisis, etc., both in Letters to Editor, Brit.J.Rheumatol 30, 1991 311-313.
Boeden Hans-Friedrich
Heinrich Hans-Werner
Meyer Udo
Neumann Hans-Georg
Ramlow Wolfgang
Goodwin & Procter LLP
Privates Institut Bioserv GmbH
Saunders David
LandOfFree
Patient-specific immunoadsorbers for the extracorporeal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Patient-specific immunoadsorbers for the extracorporeal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Patient-specific immunoadsorbers for the extracorporeal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3428171